Literature DB >> 33624007

Discordance between estimated cardiovascular risk and subclinical atherosclerosis in psoriasis: when seeing helps believing.

Shabatun J Islam1, Anurag Mehta1.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 33624007      PMCID： PMC8967479          DOI： 10.1093/eurjpc/zwaa041

Source DB:  PubMed          Journal:  Eur J Prev Cardiol        ISSN： 2047-4873            Impact factor:   8.526


× No keyword cloud information.
  19 in total

1.  Lifetime risks of cardiovascular disease.

Authors:  Jarett D Berry; Alan Dyer; Xuan Cai; Daniel B Garside; Hongyan Ning; Avis Thomas; Philip Greenland; Linda Van Horn; Russell P Tracy; Donald M Lloyd-Jones
Journal:  N Engl J Med       Date:  2012-01-26       Impact factor: 91.245

2.  Imaging subclinical atherosclerosis in cardiovascular risk stratification.

Authors:  Michaela Kozakova; Carlo Palombo
Journal:  Eur J Prev Cardiol       Date:  2020-04-11       Impact factor: 7.804

3.  Performance of four current risk algorithms in predicting cardiovascular events in patients with early rheumatoid arthritis.

Authors:  E E A Arts; C Popa; A A Den Broeder; A G Semb; T Toms; G D Kitas; P L van Riel; J Fransen
Journal:  Ann Rheum Dis       Date:  2014-01-03       Impact factor: 19.103

4.  The Framingham Risk Score underestimates the extent of subclinical atherosclerosis in patients with psoriatic disease.

Authors:  Lihi Eder; Vinod Chandran; Dafna D Gladman
Journal:  Ann Rheum Dis       Date:  2013-07-25       Impact factor: 19.103

5.  Underperformance of clinical risk scores in identifying vascular ultrasound-based high cardiovascular risk in systemic lupus erythematosus.

Authors:  George C Drosos; George Konstantonis; Petros P Sfikakis; Maria G Tektonidou
Journal:  Eur J Prev Cardiol       Date:  2020-03-02       Impact factor: 7.804

Review 6.  EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update.

Authors:  R Agca; S C Heslinga; S Rollefstad; M Heslinga; I B McInnes; M J L Peters; T K Kvien; M Dougados; H Radner; F Atzeni; J Primdahl; A Södergren; S Wallberg Jonsson; J van Rompay; C Zabalan; T R Pedersen; L Jacobsson; K de Vlam; M A Gonzalez-Gay; A G Semb; G D Kitas; Y M Smulders; Z Szekanecz; N Sattar; D P M Symmons; M T Nurmohamed
Journal:  Ann Rheum Dis       Date:  2016-10-03       Impact factor: 19.103

Review 7.  The association between psoriasis and hypertension: a systematic review and meta-analysis of observational studies.

Authors:  April W Armstrong; Caitlin T Harskamp; Ehrin J Armstrong
Journal:  J Hypertens       Date:  2013-03       Impact factor: 4.844

8.  Association of psoriasis with coronary artery, cerebrovascular, and peripheral vascular diseases and mortality.

Authors:  Srjdan Prodanovich; Robert S Kirsner; Jeffrey D Kravetz; Fangchao Ma; Lisa Martinez; Daniel G Federman
Journal:  Arch Dermatol       Date:  2009-06

9.  2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk.

Authors:  François Mach; Colin Baigent; Alberico L Catapano; Konstantinos C Koskinas; Manuela Casula; Lina Badimon; M John Chapman; Guy G De Backer; Victoria Delgado; Brian A Ference; Ian M Graham; Alison Halliday; Ulf Landmesser; Borislava Mihaylova; Terje R Pedersen; Gabriele Riccardi; Dimitrios J Richter; Marc S Sabatine; Marja-Riitta Taskinen; Lale Tokgozoglu; Olov Wiklund
Journal:  Eur Heart J       Date:  2020-01-01       Impact factor: 29.983

10.  Derivation, validation, and evaluation of a new QRISK model to estimate lifetime risk of cardiovascular disease: cohort study using QResearch database.

Authors:  Julia Hippisley-Cox; Carol Coupland; John Robson; Peter Brindle
Journal:  BMJ       Date:  2010-12-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.